Lower limits of detection, biological detection limits, functional sensitivity, or residual cancer detection limit? Sensitivity reports on prostate-specific antigen assays mislead clinicians

Clinical Chemistry

Volumn 42, Issue 6 SUPPL., 1996, Pages 849-852

  Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD; CHEMISTRY; HUMAN; IMMUNOASSAY; MALE; PROSTATE TUMOR; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE;

HUMANS; IMMUNOASSAY; MALE; MICROCHEMISTRY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE;

EID: 0030162641     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.6.849     Document Type: Article

References (17)

1. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentration of TSH. Clin Chem 1995;41:367-74.
2. Rodbard D. Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays. Anal Biochem 1978;90:1-12.
3. Vessella RL, Noteboom J, Lange PH. Evaluation of the Abbott IMx[®] automated immunoassay of prostate-specific antigen. Clin Chem 1992;38:2044-54.
4. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R. The value of serum prostate-specific antigen determinations before and after radical prostatectomy. J Urol 1989;141:873-9.
5. 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones. J Urol 1994;152:1510-4.
6. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urol 1995; 153:1004-8.
7. Klee GG, Dodge LA, Zincke H, Oesterling JE. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay. J Urol 1994;151:94-8.
8. Nicoloff JT, Spencer CA. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990;71:553-8.
9. Stamey TA, Graves HCB, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 1993;149:787-92.
10. Prestigiacomo AF, Stamey TA. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 1994;152:1515-9.
11. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid H-P. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993;71(Suppl):933-8.
12. Yu H, Diamandis EP. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin Chem 1993;39:2108-14.
13. Armbruster DA, Tillman MD, Hubbs LM. Limit of detection (LOD)/ limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem 1994;40:1233-8.
14. Lawson GM. Defining limit of detection and limit of quantitation as applied to drug of abuse testing: striving for a consensus [Editorial]. Clin Chem 1994;40:1218-9.
15. Huland H, Hammerer P, Henke R-P, Huland E. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies. J Urol 1996;155:1344-7.
16. Oesterling JE, Martin SK, Bergstralh EJ, Yemoto CEM, Stamey TA. The periurethral glands do not have a clinically significant effect on the serum PSA concentration[Abstract]. J Urol 1995; 153(Suppl):518A.
17. Iwakiri J, Grandbois K, Wehner N, Graves HCB, Stamey T. An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J Urol 1993;149:783-6.